- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Biosound begins shipping AU5 in U.S.
Biosound Esaote of Indianapolis has begun U.S. shipments of AU5, the company’s newest color-flow ultrasound scanner. AU5 was cleared by the Food and Drug Administration in August and is targeted at general imaging, vascular, intraoperative, ob/gyn,
Biosound Esaote of Indianapolis has begun U.S. shipments of AU5, the companys newest color-flow ultrasound scanner. AU5 was cleared by the Food and Drug Administration in August and is targeted at general imaging, vascular, intraoperative, ob/gyn, and intracavity applications. Esaote has shipped about 400 AU5 units internationally.
Highlights on the scanner include Digital Storage Module, which adds archiving capabilities and support for the DICOM standard. Working in conjunction with DSM is the companys ImageLab software, which turns a PC into an off-line image review workstation.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
